Providence, RI, United States of America

Paul A Dasilva-Jardine

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 149(Granted Patents)


Location History:

  • Providence, RI (US) (1997 - 2000)
  • Providence, CT (US) (2002)

Company Filing History:


Years Active: 1997-2002

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Paul A Dasilva-Jardine - Pioneer in Pharmaceutical Innovations

Paul A Dasilva-Jardine is an accomplished inventor based in Providence, RI, United States. With a remarkable portfolio comprising seven patents, he has made significant contributions to the field of pharmaceuticals.

Latest Patents

Among his most recent innovations are his patents on estrogen agonists and antagonists. These compounds are designed for treating or preventing various health conditions, including obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, and prostatic disease. His work is pivotal in advancing treatments that address these critical health issues.

Career Highlights

Dasliva-Jardine is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to be at the forefront of research and development in the pharmaceutical industry, contributing to groundbreaking solutions that enhance patient care.

Collaborations

Throughout his career, Dasilva-Jardine has collaborated with notable colleagues, including Philip Albert Carpino and Bruce A Lefker. These partnerships have likely enriched his research and contributed to the successful development of innovative therapeutic approaches.

Conclusion

In conclusion, Paul A Dasilva-Jardine's dedication to innovation in pharmaceuticals is evident through his extensive patent portfolio and collaborative efforts. His contributions not only exemplify his expertise but also hold the potential to significantly impact healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…